TY - CHAP M1 - Book, Section TI - Automatic Implantable Cardioverter-Defibrillator Assessment A1 - Roldan, Carlos J. A2 - Reichman, Eric F. PY - 2018 T2 - Reichman's Emergency Medicine Procedures, 3e AB - The introduction of implantable cardioverter-defibrillator (ICD) technology has revolutionized the fields of cardiology and electrophysiology. More than 100,000 such devices are implanted annually in the United States alone. ICDs allow life-threatening ventricular tachycardia and ventricular fibrillation to be safely controlled and benefit patients at risk for sudden cardiac death. Multiple studies have examined the prophylactic indication for ICD therapy in high-risk groups.1-7 The ICD has become a more common therapeutic option for Brugada syndrome, prolonged QT syndrome, and cardiomyopathies.8 SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/03/28 UR - accessemergencymedicine.mhmedical.com/content.aspx?aid=1159796759 ER -